<DOC>
	<DOC>NCT03053700</DOC>
	<brief_summary>This is an interventional and prospective study. The study is designed to evaluate the additional benefits of a combination of IPL treatment and local application of Bromonide 0.33% gel in the treatment of erythematotelangiectatic (ETR) and papulopustular (PPR).</brief_summary>
	<brief_title>Intense Pulsed Light as an Adjunctive to Bromonidine for the Treatment of Rosacea</brief_title>
	<detailed_description>Patients would be treated with full face application of bromonide 0.33% gel once daily for three months. In addition half of the patients' face would be subjected to three IPL treatment sessions three weeks apart from each other.</detailed_description>
	<mesh_term>Rosacea</mesh_term>
	<criteria>patient (male or female) must be over 18 yaers old of age and fulfil one of the following: 1. Suffer from ETR 2. Suffer from PPR 3. Suffer from a combination of ETR and PPR. 1.Under 18 years old of age. 2.Pregnant women. 3.Systemic treatment of rosacea at the previous six months before enrollment. 4.Topical treatment of rosacea at the previous one month before enrollment. 5.Phymatous or occular rosacae.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Rosacea, Bromonidine, intensed pulse light</keyword>
</DOC>